Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Lindsey Graham says ‘strong consensus’ to protect Kurds...
Senate Dems revolt against DHS funding bill amid...
Lindsey Graham says there’s ‘strong consensus’ to protect...
JOSH HAMMER: Case against Israel cheapens the word...
Trump hails ‘great and very brave’ UK soldiers...
Key Senator won’t fund DHS as ICE, federal...
Trump says it ‘is too late’ to stop...
Trump pushes ‘Trump-a-palooza’ midterm convention as GOP braces...
Chaos in Syria sparks fears of ISIS prison...
Trump warns Canada of 100% tariffs if it...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

by admin March 13, 2025
March 13, 2025
FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

The Food and Drug Administration’s (FDA) top lawyer, who was appointed to the position just this week, has resigned, according to a Thursday morning post on X.

‘Hilary K. Perkins has resigned from her position as Chief Counsel of FDA, effectively immediately,’ the FDA’s official X account posted.  

Perkins – a former assistant director under Biden’s Department of Justice (DOJ) in the consumer protection agency – was selected on Tuesday by acting general Sean Keveney in the Department of Health and Human Services (HHS) as part of a ‘reorganization’ effort by the department, according to an HHS news release.

She previously defended abortion pill access in a high-profile case under Biden’s DOJ, and HHS officials were reportedly unhappy with the decision to appoint Perkins but were overruled by White House officials, according to a report from Axios this week.

‘We’ve been able to recruit higher quality personnel to HHS than in any time in its history,’ HHS Secretary Robert F. Kennedy, Jr., said in a statement Tuesday at the announcement of Perkins’ assignment on Tuesday. ‘These are individuals who will return the agency to gold-standard science, evidence-based medicine, and recalibrate its trajectory toward public health rather than industry profiteering.’

Fox News Digital has reached out to the HHS and FDA for comment.

This is a breaking story, check back for updates.

This post appeared first on FOX NEWS

previous post
The Hitchhiker’s Guide to where we stand to avoid a government shutdown
next post
Senate Republicans coin ‘Schumer shutdown’ ahead of critical vote on Trump spending bill

You may also like

House Republicans divided over Obamacare as GOP eyes...

October 30, 2025

‘Intensely loyal’ Jill Biden aide despised by White...

May 28, 2025

MORNING GLORY: President Trump has just issued an...

January 23, 2025

DAVID MARCUS: What Ro Khanna told me about...

November 19, 2025

Trump budget bill hangs in balance after president...

April 9, 2025

Israeli official vows ‘We have more surprises coming...

June 14, 2025

Michelle Obama wore nearly $3K pantsuit to DNC...

August 22, 2024

Justice Jackson’s role in ‘queer’ Broadway show ‘really...

December 19, 2024

Hamas claims it will release American hostage Edan...

May 12, 2025

How to watch the Fox News – CBS...

September 30, 2024

Recent Posts

  • Lindsey Graham says ‘strong consensus’ to protect Kurds as Syrian forces advance on territory
  • Senate Dems revolt against DHS funding bill amid Minneapolis chaos, hiking government shutdown risk
  • Lindsey Graham says there’s ‘strong consensus’ to protect Kurds as Syrian forces advance on territory
  • JOSH HAMMER: Case against Israel cheapens the word ‘genocide’
  • Trump hails ‘great and very brave’ UK soldiers after slamming NATO allies’ Afghanistan service

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (967)
    • Investing (3,947)
    • Politics (4,772)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.